#London #United Kingdom #Front Line #COBRA-OS #Medical Technologies

Front Line Medical Technologies Unveils Groundbreaking COBRA-OS® in the UK Healthcare Market

Front Line Medical Technologies, renowned for its advancements in emergency and trauma medical devices, has announced the launch of its
CE-marked COBRA-OS® in the United Kingdom. This remarkable device is recognized as the world's smallest aortic occlusion tool, developed specifically to quickly manage critical bleeding during emergencies. The approval for sale in the UK has been granted under the Medical Device Regulation (MDR) as a Class III medical device, further emphasizing its credibility and effectiveness in life-saving scenarios.

The UK has played a pivotal role in the evolution of pre-hospital Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), notably since 2018. London’s Air Ambulance was the first entity to execute a pre-hospital REBOA procedure, showcasing the potential of this life-saving intervention long before patients reach hospital walls. The introduction of COBRA-OS® promises to elevate trauma care standards and enhance rapid response in life-threatening situations.

In addressing the significance of this development, Dr. Asha Parekh, the CEO of Front Line Medical Technologies, stated, "The United Kingdom represents a crucial milestone in our mission to advance aortic occlusion technology and improve trauma care outcomes. We designed this device to address critical time constraints in emergency settings, where rapid deployment and controlled occlusion can make a vital difference."

In recent years, the UK REBOA landscape has undergone significant transformation, propelled by comprehensive multicenter clinical trials, including a notable study in 2023. This has led to heightened discussions on optimal methodologies pertaining to aortic occlusion practices within trauma care. The unique features of COBRA-OS®, such as its ultra-low profile and uncomplicated deployment process, resolve many of the technical challenges encountered in conventional REBOA application.

The device is crafted to temporarily occlude the aorta, providing precious time for medical professionals until definitive treatments can commence. The following key attributes highlight its innovative design:

• - Compact Design: The ultra-low-profile 4 French size minimizes procedural risks and enhances accessibility for the medical teams.
• - Enhanced Precision: The device offers partial REBOA capabilities, allowing tailored management of blood flow during complex trauma circumstances.
• - Simplified Usage: It includes an all-in-one system complete with a 10cc syringe and mini-access kit, ensuring it can be utilized efficiently in high-pressure emergencies.

To bring the COBRA-OS® to UK healthcare professionals, Front Line Medical Technologies has partnered with Mermaid Medical, a well-respected distributor of medical supplies throughout Europe. This collaboration extends beyond the UK, covering the Nordic countries as well, taking advantage of Mermaid Medical’s extensive experience in vascular and interventional product distribution.

Sebastian Jørgensen, Marketing Director at Mermaid Medical Group, expressed excitement over this partnership, stating, "We are thrilled to strengthen our presence in the endovascular field and, together with Front Line Medical Technologies, reaffirm our shared commitment to improving patient outcomes. By offering an expanded portfolio of advanced solutions to our valued partners in the United Kingdom, we mark an important milestone in our mission to support better care."

Healthcare providers in the UK wishing to learn more about the COBRA-OS® or to arrange a personalized demonstration are encouraged to visit www.frontlinemedtech.com.

About Front Line Medical Technologies

Front Line Medical Technologies is dedicated to a singular mission—enhancing survival rates for critical patients. The organization goes beyond the confines of traditional medical device creation, striving to revolutionize emergency care with effective and straightforward solutions. At the forefront of emergency circulatory support, it has developed the COBRA-OS® (Control of Bleeding, Resuscitation, Arterial Occlusion System), recognized as the smallest life-saving aortic occlusion device available. Measuring just 4 French, this innovative technology represents a breakthrough in hemorrhage control, designed to provide essential time in emergency situations when every second is critical.